Huakang Stock's Response Announcement regarding Shanghai Stock Exchange's Regulatory Letter on the Company's 2023 Annual Report Disclosure
Tianjian Certified Public Accountants (special general partnership) Special Explanation on Information Disclosure and Regulatory Work Letter for Huakang Shares' 2023 Annual Report.
Announcement of Huakang Corporation on using some idle funds raised to redeem due for cash management.
Investor relations activity record form of Zhejiang Huakang Pharmaceutical Co., Ltd. 2024-002
Huakang Co., Ltd.'s progress announcement on the use of some idle funds raised for cash management
Announcement of Huakang Co., Ltd. on holding a performance briefing for the first quarter of 2023 and 2024
Announcement of Resolutions of the 13th Meeting of the 6th Board of Supervisors of Huakang Co., Ltd
Announcement of Huakang Co., Ltd. on the main operating data for the first quarter of 2024
Announcement of Resolutions of the 16th Meeting of the 6th Board of Directors of Huakang Co., Ltd.
Announcement of Resolutions of the 15th Meeting of the 6th Board of Directors of Huakang Co., Ltd.
Resolutions of the first special meeting of independent directors of the 6th board of directors of Huakang Co., Ltd.
Huakang Co., Ltd.'s assessment report on the performance of accounting firms in 2023
Announcement of Huakang Co., Ltd. on the main operating data for 2023
Announcement of Huakang Co., Ltd. on confirming the company's daily related transactions in 2023 and the forecast for daily related transactions in 2024
Orient Securities Underwriting and Sponsorship Co., Ltd.'s inspection opinions on Zhejiang Huakang Pharmaceutical Co., Ltd.'s daily related transactions in 2023 and expected daily related transactions in 2024
Announcement of Huakang Co., Ltd. on renewing the 2024 Audit Institution
Huakang Co., Ltd.'s special report on the storage and actual use of funds raised by the company in 2023
Verification Report on the Annual Storage and Use of Funds Raised by Huakang Co., Ltd. in 2023
Orient Securities Underwriting and Sponsorship Co., Ltd.'s special inspection opinion on the storage and use of funds raised by Zhejiang Huakang Pharmaceutical Co., Ltd. in 2023
Announcement of Huakang Co., Ltd. on the use of some idle funds raised for cash management
No Data